Improvement of SSPE by intrathecal infusion of α-IFN

Neurology

Volumn 63, Issue 2, 2004, Pages 398-399

  Kurata, T ^a   Matsubara, E ^a   Yokoyama, M ^a   Nagano, I ^a   Shoji, M ^a   Abe, K ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; IMMUNOMODULATING AGENT; INTERFERON; METHISOPRINOL;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CASE REPORT; CATHETER; DRUG INFUSION; ELECTROENCEPHALOGRAM; ENCEPHALITIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS; TREATMENT OUTCOME;

EID: 3242762931     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000130516.54312.A1     Document Type: Article

References (7)

1. Yalaz K, Anar B, Oktem F, et al. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 1992;42:488-491.
2. Gascon G, Yamanis S, Crowell J, et al. Combined oral isoprinosine- intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. Brain Dev 1993;15:346-355.
3. Anlar B, Yalaz K, Oktem F, Kose G. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular α-interferon. Neurology 1997;48:526-528.
4. Mechleb B, Khater F, Eid A, David G, Moorman JP. Late onset Ommaya reservoir infection due to Staphylococcus aureus: case report and review of Ommaya infections. J Infect 2003;46:196-198.
5. Dyken PR, Swift A, DuRant RH. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol 1982;11:359-364.
6. Risk WS, Haddad FS. The variable natural history of subacute sclerosing panencephalitis: a study of 118 cases from the Middle East. Arch Neurol 1979;36:610-614.
7. Huttenlochr PR, Mattson RH. Isoprinosine in subacute sclerosing panencephalitis. Neurology 1979;29:763-771.